Lynch Brian Joseph
- SEC CIK
- 0001776196
No open-market purchases or sales filed in the past year.
Current role at each company
- MDGL Madrigal Pharmaceuticals, Inc.SVP and General Counselas of Jan 25, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lynch Brian Joseph as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2023 (view filing) | Dec 4-5 | 2 days | Lynch Brian JosephSVP and General Counsel | SSale | −2.80K | $221.89 | −$621.3K | −15.7%15.0K after | 3 lots |
| Dec 1, 2023 (view filing) | Nov 29-30 | 2 days | Lynch Brian JosephSVP and General Counsel | SSale | −7.00K | $201.50 | −$1.41M | −31.8%15.0K after | 5 lots |
| Jan 6, 2023 (view filing) | Jan 3 | 3 daysLate | Lynch Brian JosephSVP and General Counsel | SSale | −13.0K | $282.92 | −$3.68M | −100.0%0 after | 10 lots |
| Dec 28, 2022 (view filing) | Dec 23 | 5 days | Lynch Brian JosephSVP and General Counsel | SSale | −7.00K | $274.18 | −$1.92M | −100.0%0 after | 14 lots |